Targeted Oncology Sign in to save

Aachen authors

Patent citations

–

h-index (all)

Aachen papers per year

Papers 7

A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
2023 Targeted Oncology article Medicine Monoclonal and Polyclonal Antibodies Research Open access

Rob ter Heine, Michel M. van den Heuvel, Berber Piet, Maarten J. Deenen, Anthonie J. van der Wekken, Lizza E.L. Hendriks, +14 more

17

citations
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
2023 Targeted Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access

Mahmoud Mohammadi, Nikki S. IJzerman, Dide den Hollander, Roos F. Bleckman, Astrid W. Oosten, Ingrid M.E. Desar, +3 more

16

citations
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan
2024 Targeted Oncology article Medicine Pharmaceutical studies and practices Open access

Dirk Jan A. R. Moes, Jeroen J. M. A. Hendrikx, Henk‐Jan Guchelaar, Ron H.J. Mathijssen, Vincent Olaf Dezentjé, Nikki de Rouw, +9 more

6

citations
Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients
2022 Targeted Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access

Mahmoud Mohammadi, Thekla M. Werkhoven, Nikki S. IJzerman, Dide den Hollander, Roos F. Bleckman, Astrid W. Oosten, +4 more

5

citations
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab
2024 Targeted Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Mart P. Kicken, Maarten J. Deenen, Dirk Jan A. R. Moes, Jeroen J. M. A. Hendrikx, Ben E.E.M. van den Borne, Daphne W. Dumoulin, +3 more

5

citations
Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical Practice
2021 Targeted Oncology article Medicine Lung Cancer Treatments and Mutations Open access

Lishi Lin, Egbert Frederik Smit, Adrianus Johannes De Langen, Dorieke E M van Balen, Jos H. Beijnen, Alwin D. R. Huitema

4

citations
Therapeutic Strategies Targeting the Tumor–Stromal Microenvironment in Colorectal Cancer: A Narrative Review
2026 Targeted Oncology review Medicine Colorectal Cancer Treatments and Studies Open access

Floor Heilijgers, Marie-Christine Bakker, Bente van Hest, Ingrid A. Franken, Frank M. Speetjens, Koen C.M.J. Peeters, +2 more

2

citations

7 results

Most active Aachen authors

Egbert Frederik Smit 62,735 citations overall
3 papers
Dirk Jan A. R. Moes 4,889 citations overall
3 papers
Hans A. J. Gelderblom 55,175 citations overall
2 papers
Maarten J. Deenen 2,827 citations overall
2 papers
Mahmoud Mohammadi 264 citations overall
2 papers
Henk‐Jan Guchelaar 27,269 citations overall
1 paper
Judith R. Kroep 14,032 citations overall
1 paper
Koen C.M.J. Peeters 10,688 citations overall
1 paper
Wilma E. Mesker 7,813 citations overall
1 paper
Frank M. Speetjens 2,158 citations overall
1 paper
J. Zwaveling 1,717 citations overall
1 paper
Thekla M. Werkhoven 307 citations overall
1 paper
Floor Heilijgers 37 citations overall
1 paper
Bente van Hest 2 citations overall
1 paper

Targeted Oncology ▲ Sign in to save

Aachen papers per year

Papers 7

Most active Aachen authors

Targeted Oncology Sign in to save